1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

摘要

A pharmaceutical composition containing a 1,3,5-triazine-2,4,6-triamine compound or pharmaceutically allowable salts thereof is provided to prevent and treat metabolic syndrome, diabetes, or p53-deficient cancer. A pharmaceutical composition comprises a 1,3,5-triazine-2,4,6-triamine compound represented by the formula 1. In the formula 1, R1 and R2 independently show hydrogen or a C1-C5 alkyl group; and R3 and R4 independently indicate hydrogen, C1-C7 alkyl, C3-C7 cycloalkyl, phenyl, phenyl (C1-C3)alkyl, naphthyl, naphthyl (C1-C3)alkyl, (C3-C7)heterocycloalkyl (C1-C6)alkyl, heteroaryl, or a heteroaryl (C1-C6)alkyl group or form a (C3-C8)heterocycloalkyl group with nitrogen which is bonded with R3 and R4.